Butty Audrey, Rodondi Nicolas, Nanchen David
Consultation de prévention cardiovasculaire - cholestérol et style de vie, Département promotion de la santé et prévention, Centre universitaire de médecine générale et santé publique, Unisanté, 1011 Lausanne.
Consultation des lipides, Policlinique et clinique universitaire de médecine interne générale, Hôpital de l'Ile, Université de Berne, Freiburgstrasse 15, 3010 Berne.
Rev Med Suisse. 2020 Mar 4;16(684):438-443.
Experts' guidelines for the management of dyslipidemias differ from country to country, with important differences between medical societies of Europe and the United States. Recently, new American and European guidelines have been established. These guidelines mainly differ for cardiovascular risk stratification in secondary prevention, and for LDL-cholesterol (LDL-c) goals to achieve. Similitudes between guidelines include the global strategy to initiate lipid-lowering drugs, which is based first on the global cardiovascular risk, then on the LDL-c level. We are here presenting a comparison and an interpretation of these guidelines.
不同国家的血脂异常管理专家指南各不相同，欧洲和美国的医学协会之间存在重要差异。最近，美国和欧洲制定了新的指南。这些指南在二级预防中的心血管风险分层以及要达到的低密度脂蛋白胆固醇（LDL-c）目标方面存在主要差异。指南之间的相似之处包括启动降脂药物的总体策略，该策略首先基于总体心血管风险，其次基于LDL-c水平。我们在此对这些指南进行比较和解读。
